BlackRock Inc. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 23 filers reported holding CANCER GENETICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$1,0000.0%7,608
+5.7%
0.00%
Q2 2019$1,000
-50.0%
7,195
+8.5%
0.00%
Q1 2019$2,000
+100.0%
6,632
+7.5%
0.00%
Q4 2018$1,000
-83.3%
6,167
+10.3%
0.00%
Q3 2018$6,000
+20.0%
5,590
+2.9%
0.00%
Q2 2018$5,000
-93.2%
5,433
-87.9%
0.00%
Q1 2018$74,000
-12.9%
44,920
-1.9%
0.00%
Q4 2017$85,000
-22.7%
45,767
+12.4%
0.00%
Q3 2017$110,000
-34.5%
40,734
-3.9%
0.00%
Q2 2017$168,000
+0.6%
42,370
+4.4%
0.00%
Q1 2017$167,00040,575
+579542.9%
0.00%
Q1 2014$070.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 23,937$187,0003.26%
Millrace Asset Group, Inc. 166,083$1,297,0001.43%
Sterneck Capital Management, LLC 56,950$445,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$655,0000.18%
Quality Growth Management, Inc. 23,500$184,0000.15%
TURNER INVESTMENTS LLC 99,930$781,0000.14%
ARDSLEY ADVISORY PARTNERS LP 70,700$552,0000.08%
Granite Investment Partners, LLC 110,511$863,0000.07%
DIKER MANAGEMENT LLC 23,015$180,0000.03%
Stevens First Principles Investment Advisors 1,000$8,0000.01%
View complete list of CANCER GENETICS INC shareholders